Backstaging Street-Level Discretion: Professional Bureaucrats and Organizational Adaptation under Stringent Regulatory Implementation—Evidence from Non-Selected Drug Governance in China’s Centralized Drug Procurement
This study argues that China's stringent centralized drug procurement policies do not eliminate professional discretion but rather relocate it from clinical encounters to backstage organizational routines, a phenomenon termed "backstaged street-level discretion," which transforms how bureaucrats adapt regulations through strategic gatekeeping and documentation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the complex world of modern healthcare, governments often try to control costs by setting strict rules for how much medicine costs and how much of it hospitals must buy. This approach, known as centralized procurement, is like a massive, national bulk-buying club where the government negotiates prices for common drugs to save money for everyone. The theory is simple: if the government sets a clear price and a strict target for how much to buy, doctors and hospitals will follow the rules, prices will drop, and the system will become efficient. For years, researchers have studied the numbers, confirming that prices do indeed fall and that generic medicines replace expensive brand-name ones. However, a crucial question remains unanswered: what happens inside the hospital walls when these strict rules meet the messy, unpredictable reality of treating individual patients? When a doctor knows a specific patient needs a drug that wasn't chosen for the government's bulk deal, does the rule simply stop the doctor from helping, or does the system find a different way to work?
This question sits at the heart of a new study examining how Chinese hospitals navigate the gap between rigid government targets and the actual needs of sick people. The researchers focused on "non-selected drugs," which are medicines that were not chosen for the government's special low-price deal. These are not necessarily bad drugs; they might be the original brand-name version that lost the bid, or a specialized medicine for a rare condition that didn't fit the standard categories. The study asks how the people who run the hospitals—doctors, pharmacists, and administrators—handle the pressure to use the cheap, approved drugs while still caring for patients who might need something else. By listening to conversations among these professionals in five different cities, the researchers discovered that strict rules do not actually stop doctors from making choices. Instead, the choice simply moves from the moment the doctor talks to the patient to a hidden, behind-the-scenes process where the hospital as a whole figures out how to make exceptions without breaking the rules.
The researchers gathered their insights by holding coordinated discussions with groups of stakeholders in five Chinese cities, including Fuzhou, Harbin, Suzhou, Handan, Shijiazhuang, and Shanghai. They brought together hospital leaders, insurance officers, doctors from various specialties like psychiatry and emergency care, and government officials. These were not simple interviews but structured conversations where participants explained how they actually deal with the daily pressure of the new system. The team then analyzed these conversations to build a clear picture of the hidden steps hospitals take. They found that when a government rule is too strict to be followed perfectly in every single case, the hospital does not simply ignore it. Instead, it creates a set of backstage routines to manage the conflict.
The first of these routines happens before a patient even sees a doctor. Hospitals use a "gatekeeping" system to decide which non-selected drugs are allowed to enter the building at all. A committee of experts decides which medicines stay on the official list and which are locked away. If a drug is locked away, a doctor cannot prescribe it, no matter how much they think a patient needs it. Sometimes, hospitals will keep a drug on the list but only allow it for patients who are already admitted to the hospital, effectively closing the door for people who come in for a regular check-up. This decision happens in a meeting room, far away from the patient, long before the doctor writes a prescription.
When a patient does need a drug that is locked away or restricted, the hospital has a second way to handle it: they create a special paper trail. A doctor who believes a patient needs a specific non-selected drug must write a detailed explanation of why that drug is medically necessary. This is not just a note in a file; it is a formal document that must be signed by other experts, such as pharmacists and insurance officers, who verify that the reason is valid. This process turns a doctor's personal medical judgment into a shared, auditable record. The researchers found that this paperwork acts as a filter. If the paperwork is too difficult or time-consuming to fill out, doctors might simply stop asking for the exception, even if the patient truly needs the medicine. The choice is not made in the exam room; it is made in the office, weighed against the effort required to get permission.
If the paperwork is approved but the hospital still does not have enough of the drug to go around, the third routine kicks in: rationing. The government often sets a limit on how much of a specific drug a hospital can buy. When that limit is reached, the hospital must decide which patients get the medicine and who does not. This is a difficult ethical problem. The researchers heard stories of doctors having to choose between patients based on who is sicker or which department has priority. In some cases, the hospital runs out of the medicine entirely for the month, leaving doctors with no way to treat certain patients within the standard system.
When the internal system runs out of options, the fourth routine is to send the patient elsewhere. Doctors may suggest that patients who can afford to pay buy the medicine at a private pharmacy or through a special international department within the hospital that operates outside the standard insurance rules. This is not a rejection of the patient, but a way for the hospital to satisfy the patient's need without breaking its own government targets. However, this creates a new problem: access to the medicine now depends on whether the patient has enough money to pay for it out of pocket. The researchers noted that this shifts the burden of the cost from the public insurance system to the individual family, potentially leaving poorer patients without access to the care they need.
The study also revealed that not all hospitals handle this pressure in the same way. Some hospitals, feeling the weight of strict rules and the fear of punishment, choose to play it safe. They stop using non-selected drugs almost entirely, even for patients who might benefit from them, just to avoid any risk of being penalized. The researchers call this "defensive uniformity." In these places, the system becomes rigid, and patients suffer from a lack of flexibility. Other hospitals, however, have found a different path. They create regular meetings where doctors, pharmacists, and insurance officers talk together about difficult cases. They share information about which drugs work well and which cause problems, using this real-world evidence to adjust their rules over time. These hospitals learn and adapt, finding a balance between saving money and caring for patients.
The researchers conclude that the idea that strict rules will eliminate the need for human judgment is incorrect. Instead of disappearing, the power to make choices has simply moved. It has moved from the front stage, where the doctor stands with the patient, to the back stage, where the hospital administration builds the lists, fills out the forms, and decides who gets what. This "backstage discretion" means that the rules are still being followed on paper, but the reality of patient care is being shaped by a complex set of internal decisions that are invisible to the outside observer. The study suggests that the goal of policy should not be to try to eliminate these choices, which is impossible in a complex medical system, but to make the process of making those choices clear, fair, and open to learning. If the system allows for legitimate exceptions and learns from the experiences of doctors and patients, it can save money without sacrificing the quality of care. If it does not, the system may save money on paper while leaving the most vulnerable patients behind.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.